Biomarker analysis of efficacy of PD-1 antibody combined with anti-vascular therapy for colorectal cancer
Ontology highlight
ABSTRACT: Interventions: Group of colonrectal cancer:None
Primary outcome(s): neutrophil-lymphocyte ratio
Study Design: Cross-sectional
DISEASE(S): Colonrectal Cancer
PROVIDER: 83904 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA